• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种联合生存模型,用于估计坦桑尼亚卫生保健和治疗中心接受治疗的 HIV/AIDS 患者的病毒载量结果与死亡时间之间的关联。

A joint survival model for estimating the association between viral load outcome and survival time to death among HIV/AIDS patients attending health care and treatment centers in Tanzania.

机构信息

Department of Mathematics and Statistics, University of Dodoma, Dodoma, Tanzania.

Department of Statistics, University of Dar es Salaam, Dar es Salaam, Tanzania.

出版信息

BMC Public Health. 2023 Oct 25;23(1):2091. doi: 10.1186/s12889-023-16977-x.

DOI:10.1186/s12889-023-16977-x
PMID:37880600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10598891/
Abstract

BACKGROUND

Globally, HIV/AIDS is one of the diseases that have a huge burden in terms of cost and health of individuals; and Sub-Sahara Africa is the highly affected region by the pandemic. Tanzania is among the countries that have a higher prevalence of HIV/AIDS-related mortality. This study aimed at using the joint survival model to estimate the association between viral load outcome and survival outcome to death adjusting for age, sex, adherence, and visit date.

METHODS

Secondary data from a retrospective cohort of HIV patients attending health care and treatment centers were used to analyze the association between the longitudinal viral load and time-to-death outcomes. The three-step analysis was based on the individual mixed effects linear model and the Cox proportional hazards models to estimate the significance of the independent outcomes, and the joint survival model as a final model. The joint model was used to estimate the factors affecting the average change in log viral load over time and the risk factors for the survival time of HIV patients. The exposures for both models were ART adherence status, age, male, and visit date whereas the outcome for the LMM was log viral load and the outcome for the Cox PH model was time-to-death in years.

RESULTS

The joint survival model results revealed that a 10-year increase in age was associated with a 37% increased risk of death (HR = 1.369, 95% CI: 1.253-1.844), and being male was associated with a 49% higher risk of death (HR = 1.489, 95% CI: 1.202-1.844) compared to females. The results also provided evidence of an association between the longitudinal log viral load and the survival time to death ) whereby a unit increase in the log viral load was associated with a 26% increase in the risk of death (HR = 1.262, 95% CI: 1.226-1.301).

CONCLUSION

The joint survival model analysis provided valuable insights into the associations between time to death and log viral load with adherence to ART, age, visit date, and sex of the patients. This implies that viral load suppression, as well as sex and age-specific interventions, are necessary for reducing HIV/AIDS-related deaths.

摘要

背景

在全球范围内,艾滋病毒/艾滋病是个人成本和健康负担最大的疾病之一;而撒哈拉以南非洲是受该大流行病影响最严重的地区。坦桑尼亚是艾滋病毒/艾滋病死亡率较高的国家之一。本研究旨在使用联合生存模型估计病毒载量结果和调整年龄、性别、依从性和就诊日期后与死亡相关的生存结果之间的关联。

方法

使用参加医疗保健和治疗中心的艾滋病毒患者回顾性队列的二级数据来分析纵向病毒载量与死亡时间结果之间的关联。三步分析基于个体混合效应线性模型和 Cox 比例风险模型来估计独立结果的显著性,以及最终模型联合生存模型。联合模型用于估计影响平均对数病毒载量随时间变化的因素以及艾滋病毒患者生存时间的危险因素。两个模型的暴露因素均为抗逆转录病毒治疗的依从性状况、年龄、男性和就诊日期,而 LMM 的结果是病毒载量的对数,Cox PH 模型的结果是死亡时间(以年为单位)。

结果

联合生存模型的结果表明,年龄每增加 10 岁,死亡风险增加 37%(HR=1.369,95%CI:1.253-1.844),与女性相比,男性死亡风险增加 49%(HR=1.489,95%CI:1.202-1.844)。结果还提供了纵向对数病毒载量与死亡时间之间关联的证据,即对数病毒载量增加一个单位,死亡风险增加 26%(HR=1.262,95%CI:1.226-1.301)。

结论

联合生存模型分析提供了有关时间到死亡和对数病毒载量与患者对 ART 的依从性、年龄、就诊日期和性别的关联的有价值的见解。这意味着需要进行病毒载量抑制以及针对性别和年龄的干预措施,以减少与艾滋病毒/艾滋病相关的死亡。

相似文献

1
A joint survival model for estimating the association between viral load outcome and survival time to death among HIV/AIDS patients attending health care and treatment centers in Tanzania.一种联合生存模型,用于估计坦桑尼亚卫生保健和治疗中心接受治疗的 HIV/AIDS 患者的病毒载量结果与死亡时间之间的关联。
BMC Public Health. 2023 Oct 25;23(1):2091. doi: 10.1186/s12889-023-16977-x.
2
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.在坦桑尼亚北部,一项为期两年的抗逆转录病毒治疗回顾性队列研究:艾滋病毒病毒抑制与病毒反弹风险。
BMC Infect Dis. 2024 Apr 11;24(1):390. doi: 10.1186/s12879-024-09161-y.
3
Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania.坦桑尼亚坦噶地区接受医疗保健机构抗逆转录病毒治疗的艾滋病毒成年人中病毒载量抑制失败的决定因素:一项回顾性研究。
BMC Infect Dis. 2024 Mar 14;24(1):312. doi: 10.1186/s12879-023-08604-2.
4
Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.药丸负担对接受抗逆转录病毒治疗的艾滋病毒感染和艾滋病患者的依从性、住院风险及病毒抑制的影响
Pharmacotherapy. 2016 Apr;36(4):385-401. doi: 10.1002/phar.1728. Epub 2016 Apr 13.
5
[Analysis on mortality in HIV/AIDS cases aged 15 years and older under antiretroviral treatment in Henan province, 2002-2019].[2002 - 2019年河南省15岁及以上接受抗逆转录病毒治疗的HIV/AIDS病例死亡率分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Sep 10;42(9):1594-1600. doi: 10.3760/cma.j.cn112338-20210308-00184.
6
[Survival analysis of long-term HIV/AIDS cases aged 15 years and over under antiretroviral treatment in Henan Province from 2002 to 2020].[2002年至2020年河南省15岁及以上长期接受抗逆转录病毒治疗的艾滋病病毒/艾滋病患者生存分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Jul 6;56(7):919-925. doi: 10.3760/cma.j.cn112150-20220112-00045.
7
Risk factors for interruption in treatment among HIV-infected adolescence attending health care and treatment clinics in Tanzania.坦桑尼亚感染艾滋病毒的青少年在卫生保健和治疗诊所接受治疗中断的风险因素。
AIDS Res Ther. 2023 Mar 30;20(1):19. doi: 10.1186/s12981-023-00512-4.
8
Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.坦桑尼亚西北部接受治疗和护理中心治疗的成年艾滋病毒患者在使用高效抗逆转录病毒疗法后免疫恢复不良的患病率及危险因素:一项回顾性研究
BMC Res Notes. 2017 Jun 8;10(1):197. doi: 10.1186/s13104-017-2521-0.
9
Equity of child and adolescent treatment, continuity of care and mortality, according to age and gender among enrollees in a large HIV programme in Tanzania.坦桑尼亚一项大型艾滋病毒规划中,按年龄和性别划分的儿童和青少年治疗、护理连续性和死亡率的公平性。
J Int AIDS Soc. 2018 Feb;21 Suppl 1(Suppl Suppl 1). doi: 10.1002/jia2.25070.
10
Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.HIV 诊断后进展为艾滋病和死亡的决定因素:中国武汉的一项回顾性队列研究。
PLoS One. 2013 Dec 23;8(12):e83078. doi: 10.1371/journal.pone.0083078. eCollection 2013.

引用本文的文献

1
Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies.纵向研究中多种慢性病进展模式的七种模型比较
BMJ Public Health. 2024 Nov 29;2(2):e000963. doi: 10.1136/bmjph-2024-000963. eCollection 2024 Dec.
2
Mortality and immunological indicators of men who have sex with men living with HIV on antiretroviral therapy: a 10-year retrospective cohort study in Southern China.接受抗逆转录病毒治疗的男男性行为艾滋病毒感染者的死亡率和免疫指标:中国南方一项为期10年的回顾性队列研究
BMC Infect Dis. 2025 Jan 28;25(1):135. doi: 10.1186/s12879-025-10531-3.
3
Joint modeling of longitudinal CD4 count data and time to first occurrence of composite outcome.纵向CD4细胞计数数据与复合结局首次出现时间的联合建模。
J Clin Tuberc Other Mycobact Dis. 2024 Apr 1;35:100434. doi: 10.1016/j.jctube.2024.100434. eCollection 2024 May.

本文引用的文献

1
The estimation of long and short term survival time and associated factors of HIV patients using mixture cure rate models.利用混合治愈率模型估计 HIV 患者的长期和短期生存时间及相关因素。
BMC Med Res Methodol. 2023 May 22;23(1):123. doi: 10.1186/s12874-023-01949-x.
2
Survival analysis and predictors of mortality among adult HIV/AIDS patients initiated antiretroviral therapy from 2010 to 2015 in Dubti General Hospital, Afar, Ethiopia: A retrospective cohort study.2010年至2015年在埃塞俄比亚阿法尔州杜布提综合医院开始接受抗逆转录病毒治疗的成年艾滋病毒/艾滋病患者的生存分析及死亡率预测因素:一项回顾性队列研究
Heliyon. 2023 Jan 5;9(1):e12840. doi: 10.1016/j.heliyon.2023.e12840. eCollection 2023 Jan.
3
Using joint models to study the association between CD4 count and the risk of death in TB/HIV data.利用联合模型研究 TB/HIV 数据中 CD4 计数与死亡风险之间的关联。
BMC Med Res Methodol. 2022 Nov 18;22(1):295. doi: 10.1186/s12874-022-01775-7.
4
Survival of HIV/AIDS patients treated under ART follow-up at the University hospital, northwest Ethiopia.在埃塞俄比亚西北部的大学医院接受抗逆转录病毒治疗(ART)的艾滋病病毒/艾滋病患者的生存情况。
Environ Health Prev Med. 2021 Apr 30;26(1):52. doi: 10.1186/s12199-021-00976-8.
5
Statistical Joint Modeling for Predicting the Association of CD4 Measurement and Time to Death of People Living with HIV Who Enrolled in ART, Southwest Ethiopia.埃塞俄比亚西南部接受抗逆转录病毒治疗的艾滋病毒感染者CD4测量值与死亡时间关联预测的统计联合建模
HIV AIDS (Auckl). 2021 Jan 22;13:73-79. doi: 10.2147/HIV.S283059. eCollection 2021.
6
Survival and Predictors of Mortality Among Adult HIV/AIDS Patients Initiating Highly Active Antiretroviral Therapy in Debre-Berhan Referral Hospital, Amhara, Ethiopia: A Retrospective Study.埃塞俄比亚阿姆哈拉州德布雷伯尔汉转诊医院成年艾滋病毒/艾滋病患者开始高效抗逆转录病毒治疗后的生存情况及死亡预测因素:一项回顾性研究
HIV AIDS (Auckl). 2020 Nov 18;12:757-768. doi: 10.2147/HIV.S274747. eCollection 2020.
7
Predicting the Survival of AIDS Patients Using Two Frameworks of Statistical Joint Modeling and Comparing Their Predictive Accuracy.使用两种统计联合建模框架预测艾滋病患者的生存率并比较其预测准确性。
Iran J Public Health. 2020 May;49(5):949-958.
8
Epidemiology of survival pattern and its predictors among HIV positive patients on highly active antiretroviral therapy in Southern Ethiopia public health facilities: a retrospective cohort study.埃塞俄比亚南部公共卫生机构中接受高效抗逆转录病毒治疗的艾滋病毒阳性患者的生存模式流行病学及其预测因素:一项回顾性队列研究。
AIDS Res Ther. 2020 Aug 5;17(1):49. doi: 10.1186/s12981-020-00307-x.
9
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.全球、区域和国家艾滋病毒发病率、流行率和死亡率,1980-2017 年,并预测至 2030 年,为 195 个国家和地区:全球疾病、伤害和危险因素研究 2017 年的系统分析。
Lancet HIV. 2019 Dec;6(12):e831-e859. doi: 10.1016/S2352-3018(19)30196-1. Epub 2019 Aug 19.
10
The global burden of HIV and prospects for control.全球艾滋病病毒负担与控制前景。
Lancet HIV. 2019 Dec;6(12):e809-e811. doi: 10.1016/S2352-3018(19)30230-9. Epub 2019 Aug 19.